Literature DB >> 17010310

The acidic domain of hnRNPQ (NSAP1) has structural similarity to Barstar and binds to Apobec1.

Alexandre J C Quaresma1, Sergio Oyama, João A R G Barbosa, Jörg Kobarg.   

Abstract

Apobec1 edits the ApoB mRNA by deaminating nucleotide C(6666), which results in a codon change from Glutamate to stop, and subsequent expression of a truncated protein. Apobec1 is regulated by ACF (Apobec1 complementation factor) and hnRNPQ, which contains an N-terminal "acidic domain" (AcD) of unknown function, three RNA recognition motifs, and an Arg/Gly-rich region. Here, we modeled the structure of AcD using the bacterial protein Barstar as a template. Furthermore, we demonstrated by in vitro pull-down assays that 6xHis-AcD alone is able to interact with GST-Apobec1. Finally, we performed in silico phosphorylation of AcD and molecular dynamics studies, which indicate conformational changes in the phosphorylated form. The results of the latter studies were confirmed by in vitro phosphorylation of 6xHis-AcD by protein kinase C, mass spectrometry, and spectroscopic analyses. Our data suggest hnRNPQ interactions via its AcD with Apobec1 and that this interaction is regulated by the AcD phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010310     DOI: 10.1016/j.bbrc.2006.09.044

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Poly(A) RNA-binding proteins and polyadenosine RNA: new members and novel functions.

Authors:  Callie P Wigington; Kathryn R Williams; Michael P Meers; Gary J Bassell; Anita H Corbett
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-04-30       Impact factor: 9.957

2.  Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase.

Authors:  Wenjun Hu; Nasim A Begum; Samiran Mondal; Andre Stanlie; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  The acidic domain is a unique structural feature of the splicing factor SYNCRIP.

Authors:  Christine Beuck; James R Williamson; Kurt Wüthrich; Pedro Serrano
Journal:  Protein Sci       Date:  2016-05-17       Impact factor: 6.725

4.  The RNA-editing enzyme APOBEC1 requires heterogeneous nuclear ribonucleoprotein Q isoform 6 for efficient interaction with interleukin-8 mRNA.

Authors:  Yuko Shimizu; Hironori Nishitsuji; Hiroyuki Marusawa; Saneyuki Ujino; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

5.  WHEP domains direct noncanonical function of glutamyl-Prolyl tRNA synthetase in translational control of gene expression.

Authors:  Jie Jia; Abul Arif; Partho S Ray; Paul L Fox
Journal:  Mol Cell       Date:  2008-03-28       Impact factor: 17.970

6.  Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip.

Authors:  Smita Kulkarni; Veron Ramsuran; Marijana Rucevic; Sukhvinder Singh; Alexandra Lied; Viraj Kulkarni; Colm O'hUigin; Sylvie Le Gall; Mary Carrington
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

7.  Translational upregulation of Aurora-A by hnRNP Q1 contributes to cell proliferation and tumorigenesis in colorectal cancer.

Authors:  Chien-Hsien Lai; Yu-Chuan Huang; Jenq-Chang Lee; Joseph Ta-Chien Tseng; Kung-Chao Chang; Yen-Ju Chen; Nai-Jhu Ding; Pao-Hsuan Huang; Wen-Chang Chang; Bo-Wen Lin; Ruo-Yu Chen; Yu-Chu Wang; Yi-Chien Lai; Liang-Yi Hung
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

8.  A cryptic RNA-binding domain mediates Syncrip recognition and exosomal partitioning of miRNA targets.

Authors:  Fruzsina Hobor; Andre Dallmann; Neil J Ball; Carla Cicchini; Cecilia Battistelli; Roksana W Ogrodowicz; Evangelos Christodoulou; Stephen R Martin; Alfredo Castello; Marco Tripodi; Ian A Taylor; Andres Ramos
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.